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Abstract Plant protection against pathogens, pests and
weeds has been progressively reoriented from a thera-
peutic approach to a rational use of pesticide chemicals
in which consumer health and environmental preserva-
tion prevail over any other productive or economic
considerations. Microbial pesticides are being introduced
in this new scenario of crop protection and currently
several beneﬁcial microorganisms are the active ingredi-
ents of a new generation of microbial pesticides or the
basis for many natural products of microbial origin. The
development of a microbial pesticide requires several
steps addressed to its isolation in pure culture and
screening by means of eﬃcacy bioassays performed in
vitro, ex vivo, in vivo, or in pilot trials under real con-
ditions of application (ﬁeld, greenhouse, post-harvest).
For the commercial delivery of amicrobial pesticide, the
biocontrol agent must be produced at an industrial scale
(fermentation), preserved for storage and formulated by
means of biocompatible additives to increase survival
and to improve the application and stability of the ﬁnal
product. Despite the relative high number of patents for
biopesticides, only a few of them have materialized in a
register for agricultural use. The excessive speciﬁcity in
most cases and biosafety or environmental concerns in
others are major limiting factors. Non-target eﬀects may
be possible in particular cases, such as displacement of
beneﬁcial microorganisms, allergenicity, toxinogenicity
(production of secondary metabolites toxic to plants,
animals, or humans), pathogenicity (to plants or
animals) by the agent itself or due to contaminants, or
horizontal gene transfer of these characteristics to non-
target microorganisms. However, these non-target eﬀects
should not be evaluated in an absolute manner, but
relative to chemical control or the absence of any control
of the target disease (for example, toxins derived from the
pathogen). Consumer concerns about live microbes due
to emerging food-borne diseases and bioterrorism do not
help to create a socially receptive environment to
microbial pesticides. The future of microbial pesticides is
not only in developing new active ingredients based on
microorganisms beneﬁcial to plants, but in producing
self-protected plants (so-called plant-incorporated pesti-
cides) by transforming agronomically high-value crop
plants with genes from biological control agents
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Introduction
According to the Food and Agriculture Organization
(FAO), the estimate of the world population for 2001
was 6.134·109 inhabitants (http://apps.fao.org) and the
projection towards 2025 is nearly 8.5·109 inhabitants.
Such an increase, which will occur mainly in developing
countries, will inevitably require an additional agricul-
tural production of 2.4·109 t/year. However, this addi-
tional production should not be based on an increase in
the arable surface taken from temperate or rain forest,
but on the improvement of crop productivity. This can
be achieved in part by suitable control of losses due to
biotic agents (pests, diseases, weeds), which on average
are estimated to be 38–42% of the potential production
[1, 35]. Currently, the control of plant pests, diseases and
weeds is achieved mainly by spraying crops with a vast
amount of synthetic chemical pesticides [1, 7]. However,
an increase in the use of chemical pesticides to support
the derived increase in agricultural activity needed to
sustain the expected population growth can severely
deteriorate the planet¢s health because of non-target
eﬀects.
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Microbial pesticides in the new scenario
of crop protection
Social and political concerns have inﬂuenced the practice
of crop protection that has been progressively reoriented
to a rational use of pesticides and to a reduction in the
number of registered active ingredients to those certainly
unavoidable, more selective, less toxic and with lower
negative environmental impact [15, 38]. Under this
objective, the European Union and several countries,
including the United States, have undertaken regulatory
changes in pesticide registration requirements. The
European Union has established directive 91/414/CEE
for harmonizing the register of pesticides. This projects a
reduction for the year 2008 from nearly 900 active sub-
stances existing in 1991 to less than 400 (http://euro-
pa.eu.int/comm/food) and require the presentation of a
very large dossier for each substance, providing scientiﬁc
data on toxicological studies in mammals, ecotoxicology,
traceability and environmental impact. In the United
States, the Environmental Protection Agency (EPA)
registers pesticides under the Federal Insecticide, Fungi-
cide and Rodenticide Act (FIFRA) of 1988, which in-
cludes regulatory requirements to prevent unreasonable,
adverse eﬀects on consumer health or the environment,
and theFederal Food,Drug andCosmeticAct (FFDCA),
which establishes tolerances for residues in food. The
FoodQuality ProtectionAct, approved in 1996, amended
the FIFRA and FFDCA with new safety standards.
From 610 recognized active ingredients registered
in 1995, only 382 will be retained in 2004 (http://www.
epa.gov/oppfead1/trac/factshee.htm). However, imple-
mentation of the new regulations has been diﬃcult, due to
limitations in scientiﬁc knowledge and for other reasons,
and they progress slowly, especially in the European
Union [12]. In a 5-year study (1996–2000) performed in
the European Union, monitoring pesticide residues in
fresh products of plant origin, although pesticides were
detected in 60–61% of samples, in 32–37% their levels
were belowor at themaximum residue limit (MRL) and in
3–4% of the cases were the levels above MRL [11].
Under this context, consumer health and environ-
mental preservation prevail over any other productive or
economic considerations. Consequently, the therapeutic
approach used in the past in plant protection is shifting
to a total system or sustainable pest management ap-
proach [22, 27]. However, this change in crop protection
methods generates additional problems caused by the
lack of chemical pesticides for the control of some plant
diseases of economic importance (e.g. elimination of
methyl bromide as a pesticide for soil disinfection).
New methods of crop protection are based on his-
torical observations in agriculture and forestry of the
beneﬁts obtained from naturally occurring microbial
communities, which exert a biological control of pests
and diseases [7, 8, 9, 20, 25, 39]. Biological control is
sustained by beneﬁcial interactions resulting from com-
petition, antagonism and hyperparasitism of certain
microorganisms against plant pathogens, insects and
weeds [3, 31, 32]. Currently, several microorganisms in-
volved in such processes are the active ingredients of a
new generation of microbial pesticides [6, 18, 33, 41], or
are the basis for many natural products of microbial
origin (e.g. elicitors) [17] or after chemical modiﬁcation
(e.g. phenylpyrrole fungicides) [26]. This paper discusses
only biopesticides based on living microorganisms.
Screening and development of microbial pesticides
The development of a microbial pesticide requires sev-
eral steps. The procedure consists ﬁrst of isolation in
pure culture or enrichment of the microorganism, then
identiﬁcation, characterization and performance of eﬃ-
cacy bioassays, which can be in vitro, ex vivo, or in vivo
depending on the target pathogen or pest organism, and
ﬁnally pilot trials under real conditions of application
(ﬁeld, greenhouse, post-harvest; Fig. 1).
The ﬁrst stage consists of the isolation of bacteria,
fungi, virus, or nematodes able to interfere with the
biological cycle of plant pathogens or pests. A proper
sampling can increase the probability of obtaining useful
microorganisms. For this reason, samples are taken at
places or in certain materials where there is evidence of
the presence of beneﬁcial microorganisms, such as dead
arthropods, disease-suppressive soils, or healthy plants
in epidemic areas.
However, isolation in pure culture needs suitable
methods for either cultivation in synthetic media or
enrichment in a given biological system (cellular
Fig. 1 A procedure for the screening and development of microbial
pesticides
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cultures, trap organisms). Among the microbial pesti-
cides that are easily cultivable are the entomopathogenic
fungus Paecilomyces and the biofungicidal bacterium
Pseudomonas chlororaphis, which are produced by liquid
fermentation in synthetic media. Other beneﬁcial
microorganisms are non-cultivable, such as the bacte-
rium Pasteuria penetrans, which is strictly entomopath-
ogenic [1], and the insecticidal viruses that are strict
cellular parasites and cause granulosis or nuclear poly-
hedrosis in some arthropod larvae.
Screening for antagonistic activity against the target
pest or pathogen is the critical step, because the type of
microorganism selected depends on the method used. It
usually addresses a given mechanism of action, such as
antibiosis or toxinogenesis towards the target, parasit-
ism, competition, or induction of plant defenses. During
this stage, a collection of hundreds or thousands of
isolates is performed. The isolates are submitted to eﬃ-
cacy bioassays in small-scale controlled-environment
laboratory trials towards the target pathogen, pest, or
weed, using in vitro, ex vivo, or in planta tests. However,
this process to ﬁnd suitable biological control agents
(BCAs) is time-consuming and rather random. Cer-
tainly, there is a need for easy and inexpensive screening
methods whose test conditions approach as much as
possible the real system where the biocontrol has to be
applied. A three-partner model system (putative BCA,
target organism, host plant) is recommended. A
knowledge of the mechanism of action of a BCA in
combination with an analysis of the sequence of the
corresponding genes can provide gene targets to develop
high-throughput screening procedures. Modern tech-
niques of assisted selection using phenotypic or geno-
typic markers can improve the productivity of the
screening stage. Recent advances with DNA arrays can
also contribute to develop potent screening methods.
Unfortunately, an association between some markers
and the capacity for biocontrol has been proved only in
a few cases [32]. During the selection process, additional
criteria apart from eﬃcacy and consistency of results
between bioassays are used to retain isolates, such as the
presentation of low eﬀective doses [34], the production
of speciﬁc anti-metabolites or toxins against the target
organism and a tolerance to some pesticides commonly
used in agriculture. In general, fewer than 1% satisfy the
expectations, due to the fact that the capacity of bio-
logical control is a strain-dependent subspeciﬁc charac-
teristic. Therefore, only a few strains within a given
species naturally develop such a capacity.
Pilot trials are performed under conditions as close as
possible to the real conditions under which biological
control will be developed in practice. It is convenient to
perform this stage with several pathogens or pest sys-
tems to verify the action spectrum and under environ-
mental conditions diverse enough to guarantee a wide
range of applicability, which is the most attractive
property for the pesticide industry. These limiting con-
ditions permit working only with a few isolates.
Unfortunately, most of the BCAs discovered fail at this
stage, due to their too-narrow spectrum of action, some
inconsistency in results from trial to trial, or a low eﬃ-
cacy under real conditions [19, 36, 42].
Apart from the research steps mentioned above,
additional studies are needed. Biosafety of the microbial
pesticide is extremely important to avoid non-target ef-
fects, both on plants and animals and on the environ-
ment. In the case of bacteria, the absence of a reaction of
hypersensitivity in solanaceous plants, especially in to-
bacco, is an indication of a lack of plant pathogenicity.
In the case of insects and other pest pathogens, it is
recommended also to test for the absence of negative
eﬀects on auxiliary organisms. Toxicological studies in
mammals are necessary to guarantee health of con-
sumers and handlers of the microbial pesticide, espe-
cially if the production of secondary metabolites by the
microorganism is suspected [24]. When the identiﬁcation
of the microorganism has been suﬃciently documented
and if there is no clinical or veterinary history, the tox-
icological studies do not need to be exhaustive. The most
frequent toxicological tests are oral acute toxicity in rat,
with the objective of determining the median lethal dose
(LD50) and the limit lethal dose. In the case of biocon-
trol agents based on bacteria, an acceptable LD50 should
be higher than 1011 colony-forming units/kg of animal
weight. Other tests are oriented to prove the safety of
manipulation of the concentrated product; and it is
advisable to verify the absence of dermal, eye and
inhalation irritation in guinea pig or rabbit. In certain
cases, depending on the results of acute toxicity, the
contact-delayed hypersensitivity test of Magnusson and
Klingman has to be checked. Additional tests are aimed
at detecting toxic secondary metabolites that could be
synthesized by the biocontrol agent, depending on the
fermentation conditions. In certain cases, genotoxicity
tests are also performed, usually by the Ames mutage-
nicity test.
For the commercial development of a microbial
pesticide, the biocontrol agent should be produced at the
industrial scale (fermentation), preserved, stored and
formulated [37]. In general and depending of the agent’s
nature (bacteria, fungi or yeast, nematodes, or viruses),
the methods used for industrial scale-up are solid- or
liquid-phase fermentation, which can proﬁt from the
advanced technology in the pharmaceutical and food
industries. Bacteria and yeast are usually produced by
liquid fermentation using continuously stirred tank
bioreactors, but many fungi are fermented in a solid
state [13, 14, 23]. Independent of the method used for
fermentation, the aim is to achieve the highest yield
possible with the lowest cost of culture medium, which is
achieved by using molasses, peptones, or industrial-
grade protein hydrolysates. After liquid fermentation,
the microbial cells are concentrated by ﬁltration or
centrifugation. In cases in which the microorganisms
cannot be cultured directly on synthetic media (nema-
todes, strict parasitic bacteria, viruses), the scale-up
process consists of using an alternative host or even
cellular cultures or tissue culture. An interesting example
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is the production of entomopathogenic nematodes that
feed on bacteria. The nematode Steirnema transports
bacteria of the genus Xenorhabdus and the nematode
Heterorhabditis transports bacteria of the genus
Photorhabdus [41]. Once the nematode has invaded the
insect larva, the symbiotic bacteria produce its septice-
mia and feeds the nematode within the insect. The
industrial production of this type of nematode is based
on a ﬁrst step of associated bacterial fermentation and a
second step of nematode scale-up, feeding on the
previously produced bacteria [10].
The need for storage and preservation of the micro-
bial pesticide for commercialization requires an increase
in the shelf-life, which is one of the main limiting factors
[23, 37]. The treatment consists of stabilizing the via-
bility of the microorganism. This can be achieved in li-
quid state and maintained by refrigeration, by freezing
in the presence of cryoprotectant substances, or by
keeping it as a dehydrated product. A general recipe
does not exist and each method is established empiri-
cally, but there are some starting-point conditions. The
methods based on dehydration are the best from a
practical point of view, because they allow optimum
conditions for storage, handling, distribution and for-
mulation of the microorganism. Lyophilization is the
method that best maintains viability, but its cost is very
high. Encapsulation of microbial cells is an alternative
method: it consists of mixing cells with a matrix-forming
material, such as gelatinized polysaccharide or an
emulsion in lipid material, which is ﬁnally diluted and
spray-dried to obtain particles [21]. At the industrial
level and in order to obtain a low-cost product, the
methods preferred are spray- or ﬂuidized bed- drying.
Many products are obtained by spray-drying, but this
method produces a high loss of viability in some
microorganisms (e.g. Gram-negative bacteria), due to
the thermal treatment.
Independent of the method used for the preservation
of microbial cells, the ﬁnal product should be formu-
lated before use, by means of biocompatible additives
that increase survival, improve application and stabil-
ization of the ﬁnal product, or attract or stimulate
feeding in the target pest [5]. The additives consist of
wetting and dispersal agents, nutrients and ultraviolet
light- or osmotic-protection agents. Some of these
products help the microorganism cells to survive under
ﬁeld conditions where there is damage by ultraviolet
light, low water potential, nutrient limitation or other
stress conditions [2, 28]. In many cases, this technology
is similar to that used for the formulation of chemical
pesticides and pharmaceutical products.
Knowledge of the mechanism of action of the BCA
can help to develop and improve formulation and
application systems [4, 16]. In many microbial pesticides,
the application system is similar to chemical pesticides
and is based on inundative treatment, i.e. either spraying
or drenching at high rates. However, the ideal biological
control system is based on innoculative (applied at very
low concentration and with an autonomous population
increase) or augmentative performance (low concentra-
tion but the environment is modiﬁed to favor its devel-
opment) [7, 24]. Application methods vary across
spraying or drenching plants, local application (sticks,
tablets), seed-coating and insect dispersion (bees).
Speciﬁc analysis methods are necessary not only to
control the quality of the microbial pesticide active
ingredient (the BCA) but also to study its traceability,
residue analysis and environmental impact [30, 40].
Classic microbiological methods are generally not suit-
able, because they do not distinguish the biocontrol
agent strain from its wild type present in the natural
microbiota. In certain cases, the selection of spontane-
ous mutants resistant to rifampicin (or other suitable
antibiotics for which it is rare to ﬁnd resistance in nat-
ure) may suﬃce. However, genotypic markers are pref-
erable because they are more stable and their expression
does not depend on the type of culture media used for
analysis. Getting speciﬁc genotypic markers is a diﬃcult,
time-consuming process that can be accomplished by
DNA ﬁngerprinting of the biocontrol agent strain.
These methods are based on the ampliﬁcation of gene
sequences by means of the polymerase chain reaction
(PCR; e.g. RAPD, REP, ERIC, AFLP) or by means of
DNA digestion with restriction enzymes (RFLP) [30].
By comparing the ﬁngerprint patterns of the biocontrol
strain with isolates of the same species, strain-speciﬁc
fragments can be identiﬁed, sequenced and characterized
(sequence-characterized ampliﬁed regions; SCARs).
Knowledge of the nucleotide sequence of these SCAR
fragments may form the basis for designing primers for
PCR analysis. Currently, real-time PCR (quantitative
PCR) is a strong tool for quantifying in a highly speciﬁc
way the strain of the biocontrol agent.
Patenting, registration and commercialization
of microbial pesticides
Before the commercial exploitation of a microbial pes-
ticide, its legal protection as a biotechnological inven-
tion can be assured by means of a patent. A patent is a
temporary privilege for industrial or commercial
exploitation given by the administration to the owner
for 20 years after the application date, according to a
series of claims. Biopesticide patents are considered
biotechnological inventions because they include
microbial products and processes. However, a patent is
not an authorization for commercial use (phytosanitary
registration).
As with other inventions, the ﬁling of patents for
microbial pesticides is regulated by a legal series of
national and international treaties. International trea-
ties include the Treaty of the Union of Paris of 1883,
which established a 12-month priority after the appli-
cation has been subscribed by 140 countries, the
European Patent Agreement of 1973, by which an
application is valid in 18 European countries, and the
international agreement or Patent Cooperation Treaty
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(PCT) of 1970, by which the validity of a patent ﬁled
in one of the signatory countries is valid in the other
102 countries, and an 18-month priority is established,
in addition to the 12 months in each country (a total
of 30 months). The patents of pesticides based on
microorganisms are regulated by the Budapest Treaty,
signed by all countries pertaining to the World Intel-
lectual Property Organization, which speciﬁes the need
for a pure culture of the strain of the microorganism
to be deposited in an oﬃcially recognized microbial
collection. In the European Union, the legal frame-
work is regulated by Directive 98/44CEE on the
patentability of biotechnological inventions. Because
the patents reﬂect the applied interest of a given
technology, I made a study of 215 patents involving
Fig. 2 Number of patents of microbial pesticides approved in the
United States, Europe or world-wide (Patent Cooperation Treaty)
from 1979 to 2001
Fig. 3 Distribution of microbial pesticide patents according to the
nature of the target organism (A) and the type of microbial agent
(B)
Table 1 Biopesticides based on
bacteria that are registered in
some countries. I Insecticide,
F fungicide, B bactericide,
N nematicide, H herbicide
Species/strain Type Target
Bacillus popilliae I Popilla japonica
B. thuringiensis var. aizawai I Galleria melonella
B. thuringiensis var. israeliensis I Dipteran larvae
B. thuringiensis var. kurstaki I Lepidopteran larvae
B. thuringiensis var. xentari I Lepidopteran larvae
B. thuringiensis var. San Diego I Coleopteran larvae
B. thuringiensis var. tenebrionis I Coleopteran larvae
B. thuringiensis EG2348 I Lymantria dispar
B. thuringiensis EG2371 I Lepidopteran larvae
B. thuringiensis EG2424 I Coleopteran larvae
Burkholderia cepacia F Soil-borne fungi, nematodes
Pseudomonas ﬂuorescens F Soil-borne fungi
P. syringae ESC-10, ESC-11 F Post-harvest fungi
P. chlororaphis F Soil-borne fungi
P. aureofaciens Tx-1 F Antracnose, soil-borne
Bacillus subtilis F Soil-borne fungi
B. subtilis FZB24 F Soil-borne
B. subtilis GB03 F Soil-borne and wilt
B. subtilis GB07 F Soil-borne fungi
Streptomyces griseoviridis K61 F Various fungi
S lydicus F Soil-borne
Agrobacterium radiobacter K84, K1026 B Crown gall A. tumefaciens
Ralstonia solanacearum non-pathogenic B Pathogenic R. solanacearum
Pseudomonas ﬂuorescens A506 B Frost damage, ﬁre blight (E. amylovora)
Bacillus ﬁrmus N Nematodes
Pseudomonas syringae pv. tagetis H Cirsium arvense
Xanthomonas campestris pv. poae H Poa annua
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strains of microorganisms with potential application as
microbial pesticides (fungicides, insecticides, herbicides,
or plant growth stimulants). The study includes PCT
(world patents), USPTO (United States patents) and
EPO (European patents; http://ep.espacenet.com/).
From 1986 to 2000, the number of microbial pesticide
patents increased at an average of ﬁve patents/year and
a maximum of 80 patents were approved over the
period 1998–2000, with an actual tendency to decrease
(Fig. 2). As shown in Fig. 3, most of the biopesticides
patented have fungicide activity and are made of
bacteria. Most patents for biopesticides were initially
deposited in the United States (141), United Kingdom
(18) and Australia (14).
In spite of the relatively high number of patents for
biopesticides, only a few havematerialized in a register for
agricultural use. The registration depends on speciﬁc rules
within each country. In the United States, the register is
authorized by theOﬃceof Pesticide Programs in theEPA.
The EPA has authorized for commercialization 34
bacterial strains (14 biofungicides, 2 bactericides, 16
insecticides), 17 fungi (8 fungicides, 4 herbicides, 5 insec-
ticides) and 8 viruses (mainly insecticides; see http://
www.epa.gov/pesticides/biopesticides/). In the European
Union, the register is kept by the Directorate of the
ConsumerHealthProtection and is regulated byDirective
91/414/CEE, which was been amended speciﬁcally for
biopesticides by Directive 2001/36/EC. To date (2003),
only nine applications for microbial pesticides have been
presented, including two bacteria (biofungicides), six
fungi (two insecticides, four fungicides) and one virus
(insecticide; see http://europa.eu.int/comm/food/). How-
ever, several are expected to be registered in the future.
Tables 1 and 2 show biopesticides based on bacteria
(Table 1) and fungi (Table 2) which are registered and
available on the market in some countries, with their
Table 2 Biopesticides based on
fungi that are registered in some
countries. I Insecticide,
F fungicide, N nematicide,
H herbicide
Species/strain Type Target
Beauveria bassiana I White ﬂy
Verticillium lecanii I White ﬂy
Paecilomyces fumosoroseus I White ﬂy
Metarrhizium anisopliae I Black beetle
Lagenidium giganteum I Mosquitoes
Trichoderma polysporum, T. harzianum F Soil-borne fungi
T. harzianum KRL-AG2 F Soil-borne fungi
T. harzianum F Foliar fungi
T. harzianum, T. viride F Various
T. viride F Various
T. lignorum F Vascular wilt
Trichoderma spp F Soil-borne
Ampelomyces quisqualis M-10 F Powdered mildew
Talaromyces ﬂavus V117b F Soil-borne fungi
Gliocladium virens GL-21 F Soil-borne fungi
G. catenulatum F Soil-borne fungi
Fusarium oxysporum non-pathogenic F Pathogenic Fusarium
Pythium oligandrum F Phytium ultimum
Phlebiopsis gigantea F Heterobasidium
Coniothyrium minitans F Sclerotinia sclerotiorum
Candida oleophila I-182 F Post-harvest rot
Myrothecium verrucaria N Nematodes
Paecilomyces ilacinus N Nematodes
Phytophthora palmivora MWV H Morrenia odorata
Colletotrichum gloeosporioides H Cuscuta and various
C. gloeosporioides f.sp. malvae H Malva pulsilla
C. g. f.sp. aeschynomene H Curty indigo
C. coccodes H Abutilon theophrasti
C. truncatum H Sesbania exalta
Alternaria cassia H Senna obtusifolia
Table 3 Biopesticides based on
viruses that are registered in
some countries. I Insecticide,
F fungicide
Species/strain Type Target
Granulosis virus I Byctiscus betulae, codling moth
Pine sawﬂy NPV I Diprion similis
Heliothis NPV I Helicoverpa zeae
Gypsy moth NPV I Lymantria dispar
Tussok moth NPV I Orgyia pseudotsugata
Mamestria brassicae NPV I Heliothis
Spodoptera exigua virus I S. exigua
Bacteriophage of P. tolaasii F Bacterial rot of mushroom
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target organisms. The biopesticides based on viruses
(Table 3) are mainly insecticides. They include diﬀerent
types of granulosis and nuclear polyhedrosis virus and a
bactericide based on the bacterium Pseudomonas tolaasii.
Future prospects
In spite of the relatively abundant number of patents for
microbial pesticides, the number of commercial appli-
cations has not been as dramatic as expected. Analysis
of the patents of microbial pesticides indicates that the
research has usually originated from universities or
public administrations. However, the number of private
companies interested in registering new biopesticides is
increasing, especially in the United States; and they
correspond to a typical proﬁle of small- to medium-sized
companies. In Europe, the limiting factor for registra-
tion, apart from the cost, is undoubtedly the slow pro-
cess of decision-taking. As an example, the ﬁrst
application for patenting a biopesticide, Paecilomyces
fumosoroseus, was submitted to the European Union
in 1994 and approved only in 2001. In most cases,
excessive speciﬁcity is a problem diﬃcult to solve be-
cause it is intrinsic to the biological control system. In
fact, success depends on three living systems: the path-
ogen or pest, the BCA and the host plant.
Biosafety and environmental concerns are also major
limiting factors for microbial pesticide prospects. Non-
target eﬀects have been object of a review by Mathre
et al. [32], who pointed out possible problems, such as
displacement of beneﬁcials including micorhizae or
symbiotic rizobacteria, allergenicity, toxinogenicity
(production of secondary metabolites toxic to plants,
animals, or humans), or pathogenicity (to plants or
animals) by the agent itself or due to contaminants.
Problems may also derive from horizontal gene transfer
of these characteristics to non-target microorganisms.
All these non-target eﬀects, however, should not be
evaluated in an absolute manner, but in a case-by-case
manner, relative to chemical control or the absence of
any control of the target disease (for example toxins
derived from the pathogen).
Consumer concerns about live microbes related to
limited information about safe and harmful microbes
cannot be overlooked. Certainly, emerging food-borne
diseases and the threat of bioterrorism do not help to
create a socially receptive environment for microbial
pesticides. The future of microbial pesticides is not only
in developing new active ingredients based on microor-
ganisms beneﬁcial to plants, but in producing self-pro-
tected plants (so-called plant-incorporated pesticides) by
transforming agronomically high-value crop plants with
genes from BCAs [29].
References
1. Agrios NG (1997) Plant pathology. Academic Press, San Diego
2. Andrews JH, Harris RF (2000) The ecology and biogeography
of microorganisms on plant surfaces. Annu Rev Phytopathol
38:145–180
3. Backman PA, Wilson M, Murphy JF (1997) Bacteria for bio-
logical control of plant diseases. In: Rechcigl NA, Rechcigl JE
(eds) Environmentally safe approaches to crop disease control.
CRC/Lewis Press, Boca Raton, Fla., pp 95–109
4. Boland GJ, Kuykendall LD (1998) Plant–microbe interactions
and biological control. Dekker, New York
5. Boyetchko S, Pedersen E, Punja Z, Reddy M (1998) Formu-
lations of biopesticides. In: Hall FR, Barry JW (eds) Biopesti-
cides: use and delivery. (Methods in biotechnology, vol 5)
Humana Press, Totowa, N.J., pp 487–508
6. Chet I (1993) Biotechnology in plant disease control. Wiley–
Liss, New York
7. Cook RJ (2000) Advances in plant health management in the
20th century. Annu Rev Phytopathol 38:95–116
8. Cook RJ, Baker KF (1983) The nature and practice of bio-
logical control of plant pathogens. APS, St Paul, Minn.
9. Dent DR, Walton MP (1997) Methods in ecological and agri-
cultural entomology. CAB International, London
10. Ehlers RU, Niemann I, Hollmer S, Strauch O, Jende D,
Shanmugasundaran M, Mehta UK, Easwaramoorthy S, Bur-
nell A (2000) Mass production potential of the bacto-helmin-
thic biocontrol complex Heterorhabditis indica–Photorhabdus
luminescens. Biocontr Sci Technol 10:607–616
11. European Commission (2002) Monitoring of pesticide residues
in products of plant origin in the European Union, Norway,
Iceland and Liechtenstein. (Document SANCO/687/02) Euro-
pean Commission, Brussels
12. European Commission (2003) Overview of the state of main
works in DG health and consumer protection E.1 with regard
to the implementation of Directive 91/414/EEC. (Document
SANCO/629/00) European Commission, Brussels
13. Fravel DR, Rhodes DJ, Larkin RP (1999) Production and
commercialization of biocontrol products. In: Albajes R,
Gullino LM, Lenteren JC van, Elad Y (eds) Integrated pest and
disease management in greenhouse crops. Kluwer, Dordrecht,
pp 365–376
14. Glazer AN, Nikaido H (1995) Microbial biotechnology. Free-
man, New York
15. Gullino ML, Kuijpers LAM (1994) Social and political impli-
cations of managing plant diseases with restricted fungicides in
Europe. Annu Rev Phytopathol 32:559–579
16. Gutterson N (1990) Microbial fungicides: recent approaches to
elucidating mechanisms. Crit Rev Biotechnol 10:69–91
17. Hahn MG (1996) Microbial elicitors and their receptors in
plants. Annu Rev Phytopathol 34:387–412
18. Hall FR, Barry JW (1995) Biorational pest control agents.
American Chemical Society, Washington, D.C.
19. Harman GE (2000) Myths and dogma of biocontrol: changes in
perceptions derived from research on Tricleoderma harzianum
T-22. Plant Dis 84:377–393
20. Hoitink HAJ, Boehm MJ (1999) Biocontrol within the context
of soil microbial communities: a substrate-dependent phe-
nomenon. Annu Rev Phytopathol 37:427–446
21. Jackson SJ, Leek R (1991) Microencapsulation and the food
industry. Lebensm Wiss Technol 24:289–297
22. Jime´nez-Dı´az RM, Lamo de Espinosa J (1998) Sustainable
agriculture (In Spanish). Mundi Prensa, Madrid
23. Jones DG (1993) Exploitation of microorganisms. Chapman
Hall, London
24. KEMI (1998) Microbiological plant protection prod-
ucts—workshop on the scientiﬁc basis for risk assessment.
National Chemicals Inspectorate of Sweden, Stockholm
25. Kerry BR (2000) Rhizosphere interactions and the exploitation
of microbial agents for the biological control of plant–parasitic
nematodes. Annu Rev Phytopathol 38 423–441
26. Knight SC, Anthony VM, Brady AM, Greenland AJ, Heaney
SP, Murray DC, Powell KA, Schulz MA, Spinks CA, Wor-
thington PA, Youle D (1997) Rationale and perspectives on the
development of fungicides. Annu Rev Phytopathol 35:349–372
251
27. Lewis WJ, Leuteren JC van, Phatak SC, Tumlinson JH III
(1997) A total system approach to sustainable pest manage-
ment. Proc Natl Acad Sci USA 94:12243–12248
28. Lindow SE, Hecht-Poinar EA, Elliot VJ (2002) Phyllosphere
microbiology. APS Press, Saint Paul, Minn.
29. Lorito M, Scala F (1999) Microbial genes expressed in
transgenic plants to improve disease resistance. J Plant Pathol
81:73–88
30. Louws FJ, Rademaker JLW, Bruijn FJ de (1999) The three Ds
of PCR-based genomic analysis of phytobacteria: diversity,
detection, and disease diagnosis. Annu Rev Phytopathol 37:81–
125
31. Maddox JV (1994) Insect pathogens as biological control
agents. In: Metcalf RL, Luckmann WH (eds) Introduction to
insect pest management. Wiley, New York
32. Mathre DE, Cook RJ, Callan NW (1999) From discovery to
use: traversing the world of commercializing biocontrol agents
for plant disease control. Plant Dis 83:972–983
33. McSpadden BB, Fravel D (2002) Biological control of plant
pathogens: research, commercialization, and application in the
USA. Plant Health Progress, Washington, D.C. (www.plant-
managmentnetwork.org/php/)
34. Montesinos E, Bonaterra A (1996) Dose-response models in
biological control of plant pathogens. An empirical veriﬁcation.
Phytopathology 86:464–472
35. Oerke EC, Dehne HW, Shoenbeck F, Weber A (1994) Esti-
mated losses in major food and cash crops. Elsevier, London
36. Paulitz TC, Be´langer RB (2001) Biological control in green-
house systems. Annu Rev Phytopathol 39:103–133
37. Powell KA, Jutsum AR (1993) Technical and commercial
aspects of bicontrol products. J Pestic Sci 37:315–321
38. Ragsdale NN, Sisler HD (1994) Social and political implica-
tions of managing plant diseases with decreased availability of
fungicides in the United States. Annu Rev Phytopathol
32:545–557
39. Rodrı´guez-Ka´bana R, Canullo GH (1992) Cropping systems
for the management of phytonematodes. Phytoparasitica
20:211–224
40. Schena L, Ippolito A, Zahavi T, Droby S (2000) Molecular
approaches to assist the screening and monitoring of post-
harvest biocontrol yeasts. Eur J Plant Pathol 106:681–691
41. Stirling GR (1991) Biological control of plant parasitic nema-
todes: progress, problems and prospects. CAB International,
Wallingford
42. Wilson M, Backman PA (1998) Biological control of plant
pathogens. In: Ruberson JR (ed) Handbook of pest manage-
ment. Dekker, New York, pp 325–331
252
